Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease
Violeta Raverdy(Inserm), François Pattou(Inserm), Carel W. le Roux(University College Dublin), Chiara Saponaro(University of Pisa), Stefano Romeo(Sahlgrenska University Hospital), Samuel Blanck(Université de Lille), Viviane Gnemmi(Université Paris-Saclay), Lisa Olsson(Wallenberg Wood Science Center), Hannele Yki‐Järvinen(University of Helsinki), Umberto Vespasiani‐Gentilucci(Università Campus Bio-Medico), Philippe Lefèbvre(University of Liège), Robert Caïazzo(Université de Lille), Jimmy Vandel(Centre National de la Recherche Scientifique), Grégory Baud(Inserm), Hélène Verkindt(Inserm), Guillemette Marot(Institut national de recherche en sciences et technologies du numérique), Emmanuelle Leteurtre(Université de Lille), Joel T. Haas(Gladstone Institutes), Estelle Chatelain(Centre National de la Recherche Scientifique), Mikaël Chetboun(Inserm), Camille Marciniak(Centre Hospitalier Universitaire de Lille), Rima Chakaroun(Sahlgrenska University Hospital), Naima Oukhouya‐Daoud(Inserm), Sven Francque(Inova Health System), Guillaume Lassailly(Inserm), Antonio De Vincentis(Università Campus Bio-Medico), Valentina Tremaroli(University of Gothenburg), Julie Kerr‐Conte(Inserm), Federica Tavaglione(Università Campus Bio-Medico), Bart Staels(Inserm), Philippe Mathurin(Inserm), S. U. Qadri(University of Helsinki)
Cited by 153
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
|New England Journal of Medicine|2015|2.6k